Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133390) titled 'Research on the Prevention of VTE with Atoxaban' on Sept. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Dalian Medical University
Condition:
Malignant tumors with moderate to high risk of venous thromboembolism
Intervention:
blank control group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2023-03-08
Target Sample Size: blank control group:37;experimental group:38;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334800
Published by HT Digital Content Servic...